Latest Doxil Stories
- Note: This release corresponds to ASH abstracts 22, 31, 78, 84, 176, 327, 505, 2096, 2312, 3448, 3474, 4454, 4469, 4680 RARITAN, N.J., Nov.
The Food and Drug Administration (FDA) announced plans on Tuesday to help resupply the U.S. with two leading cancer drugs.
HORSHAM, Pa., Sept. 10 /PRNewswire/ -- Centocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter from the U.S.
HORSHAM, Pa., July 15 /PRNewswire/ -- Based on the data presented today, the U.S.
SAN ANTONIO, Dec.
Ortho Biotech Products, a biopharmaceutical company, has submitted a supplemental new drug application to the FDA for the combination of Doxil and Taxotere for the treatment of women with advanced breast cancer who have received prior anthracycline treatment.
BRIDGEWATER, N.J., Sept. 8 /PRNewswire/ -- Ortho Biotech Products, L.P. today announced that the Company has submitted a supplemental new drug application (sNDA) to the U.S.
- The parings of haberdine; also, any kind of fragments.